The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment

The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment

Non-small cell lung cancer (NSCLC) is a prominent etiology of cancer-related mortality. The heterogeneous nature of this disease impedes its accurate diagnosis and efficacious treatment. Consequently, constant advancements in research are imperative in order to comprehend its intricate nature. In ad...

Full description

Bibliographic Details
Main Authors: Lei Peng, Quan Xu, Sui Yin, Ye Zhang, Hao Wu, Yangchun Liu, Liru Chen, Yeji Hu, Jun Yuan, Kai Peng, Qin Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
immunotherapy
nanomedicine
nanotechnology
combined therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1153319/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1153319/full

Similar Items